PRLD

Prelude Therapeutics
PRLD

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$48.71M
EV
$-66.88M
Shares Outstanding
55.15M
Beta
1.34

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$3.33
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Prelude Therapeutics Incorporated

gainify
PRLD

Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clin...

Sector

Healthcare

Industry

Biotechnology

CEO

Vaddi, Krishna

Employees

131

IPO Date

2020-09-25

Headquarters

175 Innovation Boulevard, Wilmington, Delaware, 19805, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved